January Abbott / AbbVie stock price prediction

Comment: Based on calculations from previous post. We'll see how close I am.

Abbott / AbbVie dividends

Abbott Declares 356th Consecutive Quarterly Dividend
Excerpt:

The board of directors of Abbott today declared its 356th consecutive quarterly cash dividend. The quarterly dividend is $0.14 per share, payable Feb. 15, 2013, to shareholders of record on Jan. 15, 2013. The management of AbbVie, Abbott's research-based pharmaceuticals business, intends to recommend a cash dividend, subject to AbbVie board approval, of $0.40 per share, which together with Abbott's dividend will equal a cash dividend of $0.54 per share, an increase of nearly 6 percent over Abbott's quarterly cash dividend declared in September 2012.

Abbott's annualized cash dividend of $0.56 per share, combined with AbbVie's annualized cash dividend of $1.60 per share equals a total annualized cash dividend of $2.16 per share, compared to the annualized cash dividend of Abbott, prior to separation, of $2.04 per share. Future quarterly dividends, including the expected AbbVie dividend in February 2013, are subject to approval by each company's board of directors.

Comment: Split to occur in January

The Abbott AbbVie split

Abbott Labs to Split Into 2 Companies
Excerpt:

Barring any regulatory surprises, Abbott Laboratories (ABT) will officially separate into two companies Jan. 1, 2013, entering a new era shying away from mega-mergers.

The suburban Chicago drug and medical product giant is splitting into a medical products business that will be called AbbVie, and trade under a new ticker symbol, ABBV, while the other company will retain the Abbott name and largely be focused on medical products including devices, diagnostics and nutritional products.

Comment: Hopefully unlocks stock holder value.